Technical Analysis for REPL - Replimune Group, Inc.

Grade Last Price % Change Price Change
grade D 12.2 -10.56% -1.44
REPL closed down 10.56 percent on Friday, November 15, 2019, on 6.72 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical REPL trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Volume Surge Other 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Support Bullish -10.56%
Pocket Pivot Bullish Swing Setup -10.56%

Older signals for REPL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP, RP2, and RP3. The Company is focused on Phase 1/2 clinical trial with its lead product candidate, RP1, in approximately 150 patients with a range of solid tumors.
Medicine Biotechnology Cancer Clinical Medicine Immunotherapy Solid Tumors Cancer Treatments Virotherapy Experimental Cancer Treatments Transgene Sa
Is REPL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 18.25
52 Week Low 8.88
Average Volume 121,926
200-Day Moving Average 13.5792
50-Day Moving Average 14.2238
20-Day Moving Average 15.7865
10-Day Moving Average 15.812
Average True Range 1.2232
ADX 45.88
+DI 15.2781
-DI 29.8017
Chandelier Exit (Long, 3 ATRs ) 14.0104
Chandelier Exit (Short, 3 ATRs ) 15.8696
Upper Bollinger Band 18.5896
Lower Bollinger Band 12.9834
Percent B (%b) -0.14
BandWidth 35.512622
MACD Line 0.0983
MACD Signal Line 0.663
MACD Histogram -0.5647
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.47
Resistance 3 (R3) 14.73 14.22 14.09
Resistance 2 (R2) 14.22 13.64 14.09 13.97
Resistance 1 (R1) 13.21 13.28 12.96 12.96 13.84
Pivot Point 12.71 12.71 12.58 12.58 12.71
Support 1 (S1) 11.70 12.13 11.44 11.44 10.56
Support 2 (S2) 11.19 11.77 11.06 10.43
Support 3 (S3) 10.18 11.19 10.31
Support 4 (S4) 9.93